Osteoarthritis, genetic and molecular mechanisms

Osteoarthritis (OA) is the most common musculoskeletal disorder world-wide and has enormous social and economic consequences. OA is a multifactorial disorder in which ageing, genetic, hormonal and mechanical factors are all major contributors to its onset and progression. The primary lesion in OA wo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biogerontology (Dordrecht) 2002, Vol.3 (1-2), p.85-88
Hauptverfasser: GHOSH, Peter, SMITH, Margaret
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 88
container_issue 1-2
container_start_page 85
container_title Biogerontology (Dordrecht)
container_volume 3
creator GHOSH, Peter
SMITH, Margaret
description Osteoarthritis (OA) is the most common musculoskeletal disorder world-wide and has enormous social and economic consequences. OA is a multifactorial disorder in which ageing, genetic, hormonal and mechanical factors are all major contributors to its onset and progression. The primary lesion in OA would appear to occur in the articular cartilage (AC) which covers the weight-bearing surfaces of diarthrodial joints. Studies on AC have shown a decline in the chondrocyte numbers and their viability with ageing; largely due to nitric oxide radical mediated apoptosis. Since chondrocytes are responsible for the synthesis of the extensive extracellular matrix of AC, their decline in numbers limits the AC's ability to maintain homeostasis and thus functionality. Moreover, the chondrocytes remaining in the AC show diminished capacity to respond to growth factors which also restricts repair and their metabolism is greatly affected by cytokines and nitric oxide free radical produced during synovial inflammation and the imposition of supranormal mechanical stresses. Proteoglycans (PGs) provide the resilience of AC and a reduction in their synthesis, molecular size and increased catabolism in OA joints, markedly impairs AC capacity to efficiently respond to mechanical stress, leading to fibrillation and erosion down to subchondral bone. Recent OA research has sought to identify modalities which retard, or even reverse these pathological events. While many claims of disease modifying drugs in OA (DMOAD) have been made, our research has indicated that calcium pentosan polysulfate (CaPPS) exhibits considerable potential in this regard. CaPPS corrects many of the phenotypic imbalances (described above) in chondrocyte metabolism and promotes the synthesis of large PGs. Furthermore, it inhibits the enzymes responsible for PG and collagen degradation and increases the translation of tissue inhibitor of metalloproteinase-3 (TIMP-3) by synoviocytes and chondrocytes, thereby, reducing proteolytic and angiogenic activity within the joint space.
doi_str_mv 10.1023/a:1015219716583
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71691604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2156603781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-12b8fae77410cded3016b38c228689fc5f9af787f7ff7d9ea1cdcaf9ef3fb923</originalsourceid><addsrcrecordid>eNpd0EtLAzEQB_Agiq3VszdZBD25mkk2L29SfEGhl96X2Wxit-yjJrsHv70BK4KnmcOPmfkPIZdA74Ey_oCPQEEwMAqk0PyIzEEonksl9XHquTa5UMzMyFmMO0pBMilOyQwYhUIXZk7oOo5uwDBuQzM28S77cL0bG5thX2fd0Do7tRiyztkt9k3s4jk58dhGd3GoC7J5ed4s3_LV-vV9-bTKLVdyzIFV2qNTqgBqa1fztLvi2jKmpTbeCm_QK6288l7VxiHY2qI3znNfGcYX5PZn7D4Mn5OLY9k10bq2xd4NUyxTXgOSFgle_4O7YQp9Oq1UQhoqudYJXR3QVHWuLveh6TB8lb9_SODmADBabH3A3jbxz_H03BSFfwOREGv7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756906388</pqid></control><display><type>article</type><title>Osteoarthritis, genetic and molecular mechanisms</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>GHOSH, Peter ; SMITH, Margaret</creator><creatorcontrib>GHOSH, Peter ; SMITH, Margaret</creatorcontrib><description>Osteoarthritis (OA) is the most common musculoskeletal disorder world-wide and has enormous social and economic consequences. OA is a multifactorial disorder in which ageing, genetic, hormonal and mechanical factors are all major contributors to its onset and progression. The primary lesion in OA would appear to occur in the articular cartilage (AC) which covers the weight-bearing surfaces of diarthrodial joints. Studies on AC have shown a decline in the chondrocyte numbers and their viability with ageing; largely due to nitric oxide radical mediated apoptosis. Since chondrocytes are responsible for the synthesis of the extensive extracellular matrix of AC, their decline in numbers limits the AC's ability to maintain homeostasis and thus functionality. Moreover, the chondrocytes remaining in the AC show diminished capacity to respond to growth factors which also restricts repair and their metabolism is greatly affected by cytokines and nitric oxide free radical produced during synovial inflammation and the imposition of supranormal mechanical stresses. Proteoglycans (PGs) provide the resilience of AC and a reduction in their synthesis, molecular size and increased catabolism in OA joints, markedly impairs AC capacity to efficiently respond to mechanical stress, leading to fibrillation and erosion down to subchondral bone. Recent OA research has sought to identify modalities which retard, or even reverse these pathological events. While many claims of disease modifying drugs in OA (DMOAD) have been made, our research has indicated that calcium pentosan polysulfate (CaPPS) exhibits considerable potential in this regard. CaPPS corrects many of the phenotypic imbalances (described above) in chondrocyte metabolism and promotes the synthesis of large PGs. Furthermore, it inhibits the enzymes responsible for PG and collagen degradation and increases the translation of tissue inhibitor of metalloproteinase-3 (TIMP-3) by synoviocytes and chondrocytes, thereby, reducing proteolytic and angiogenic activity within the joint space.</description><identifier>ISSN: 1389-5729</identifier><identifier>EISSN: 1573-6768</identifier><identifier>DOI: 10.1023/a:1015219716583</identifier><identifier>PMID: 12014849</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Apoptosis ; Biological and medical sciences ; Cartilage ; Cartilage, Articular - anatomy &amp; histology ; Cartilage, Articular - physiology ; Diseases of the osteoarticular system ; Extracellular Matrix - metabolism ; Free radicals ; Humans ; Juxtaarticular diseases. Extraarticular rhumatism ; Medical sciences ; Osteoarthritis - genetics</subject><ispartof>Biogerontology (Dordrecht), 2002, Vol.3 (1-2), p.85-88</ispartof><rights>2002 INIST-CNRS</rights><rights>Kluwer Academic Publishers 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-12b8fae77410cded3016b38c228689fc5f9af787f7ff7d9ea1cdcaf9ef3fb923</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,4010,4036,4037,23911,23912,25120,27902,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13583741$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12014849$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GHOSH, Peter</creatorcontrib><creatorcontrib>SMITH, Margaret</creatorcontrib><title>Osteoarthritis, genetic and molecular mechanisms</title><title>Biogerontology (Dordrecht)</title><addtitle>Biogerontology</addtitle><description>Osteoarthritis (OA) is the most common musculoskeletal disorder world-wide and has enormous social and economic consequences. OA is a multifactorial disorder in which ageing, genetic, hormonal and mechanical factors are all major contributors to its onset and progression. The primary lesion in OA would appear to occur in the articular cartilage (AC) which covers the weight-bearing surfaces of diarthrodial joints. Studies on AC have shown a decline in the chondrocyte numbers and their viability with ageing; largely due to nitric oxide radical mediated apoptosis. Since chondrocytes are responsible for the synthesis of the extensive extracellular matrix of AC, their decline in numbers limits the AC's ability to maintain homeostasis and thus functionality. Moreover, the chondrocytes remaining in the AC show diminished capacity to respond to growth factors which also restricts repair and their metabolism is greatly affected by cytokines and nitric oxide free radical produced during synovial inflammation and the imposition of supranormal mechanical stresses. Proteoglycans (PGs) provide the resilience of AC and a reduction in their synthesis, molecular size and increased catabolism in OA joints, markedly impairs AC capacity to efficiently respond to mechanical stress, leading to fibrillation and erosion down to subchondral bone. Recent OA research has sought to identify modalities which retard, or even reverse these pathological events. While many claims of disease modifying drugs in OA (DMOAD) have been made, our research has indicated that calcium pentosan polysulfate (CaPPS) exhibits considerable potential in this regard. CaPPS corrects many of the phenotypic imbalances (described above) in chondrocyte metabolism and promotes the synthesis of large PGs. Furthermore, it inhibits the enzymes responsible for PG and collagen degradation and increases the translation of tissue inhibitor of metalloproteinase-3 (TIMP-3) by synoviocytes and chondrocytes, thereby, reducing proteolytic and angiogenic activity within the joint space.</description><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Cartilage</subject><subject>Cartilage, Articular - anatomy &amp; histology</subject><subject>Cartilage, Articular - physiology</subject><subject>Diseases of the osteoarticular system</subject><subject>Extracellular Matrix - metabolism</subject><subject>Free radicals</subject><subject>Humans</subject><subject>Juxtaarticular diseases. Extraarticular rhumatism</subject><subject>Medical sciences</subject><subject>Osteoarthritis - genetics</subject><issn>1389-5729</issn><issn>1573-6768</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0EtLAzEQB_Agiq3VszdZBD25mkk2L29SfEGhl96X2Wxit-yjJrsHv70BK4KnmcOPmfkPIZdA74Ey_oCPQEEwMAqk0PyIzEEonksl9XHquTa5UMzMyFmMO0pBMilOyQwYhUIXZk7oOo5uwDBuQzM28S77cL0bG5thX2fd0Do7tRiyztkt9k3s4jk58dhGd3GoC7J5ed4s3_LV-vV9-bTKLVdyzIFV2qNTqgBqa1fztLvi2jKmpTbeCm_QK6288l7VxiHY2qI3znNfGcYX5PZn7D4Mn5OLY9k10bq2xd4NUyxTXgOSFgle_4O7YQp9Oq1UQhoqudYJXR3QVHWuLveh6TB8lb9_SODmADBabH3A3jbxz_H03BSFfwOREGv7</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>GHOSH, Peter</creator><creator>SMITH, Margaret</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Osteoarthritis, genetic and molecular mechanisms</title><author>GHOSH, Peter ; SMITH, Margaret</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-12b8fae77410cded3016b38c228689fc5f9af787f7ff7d9ea1cdcaf9ef3fb923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Cartilage</topic><topic>Cartilage, Articular - anatomy &amp; histology</topic><topic>Cartilage, Articular - physiology</topic><topic>Diseases of the osteoarticular system</topic><topic>Extracellular Matrix - metabolism</topic><topic>Free radicals</topic><topic>Humans</topic><topic>Juxtaarticular diseases. Extraarticular rhumatism</topic><topic>Medical sciences</topic><topic>Osteoarthritis - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GHOSH, Peter</creatorcontrib><creatorcontrib>SMITH, Margaret</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Biogerontology (Dordrecht)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GHOSH, Peter</au><au>SMITH, Margaret</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteoarthritis, genetic and molecular mechanisms</atitle><jtitle>Biogerontology (Dordrecht)</jtitle><addtitle>Biogerontology</addtitle><date>2002</date><risdate>2002</risdate><volume>3</volume><issue>1-2</issue><spage>85</spage><epage>88</epage><pages>85-88</pages><issn>1389-5729</issn><eissn>1573-6768</eissn><abstract>Osteoarthritis (OA) is the most common musculoskeletal disorder world-wide and has enormous social and economic consequences. OA is a multifactorial disorder in which ageing, genetic, hormonal and mechanical factors are all major contributors to its onset and progression. The primary lesion in OA would appear to occur in the articular cartilage (AC) which covers the weight-bearing surfaces of diarthrodial joints. Studies on AC have shown a decline in the chondrocyte numbers and their viability with ageing; largely due to nitric oxide radical mediated apoptosis. Since chondrocytes are responsible for the synthesis of the extensive extracellular matrix of AC, their decline in numbers limits the AC's ability to maintain homeostasis and thus functionality. Moreover, the chondrocytes remaining in the AC show diminished capacity to respond to growth factors which also restricts repair and their metabolism is greatly affected by cytokines and nitric oxide free radical produced during synovial inflammation and the imposition of supranormal mechanical stresses. Proteoglycans (PGs) provide the resilience of AC and a reduction in their synthesis, molecular size and increased catabolism in OA joints, markedly impairs AC capacity to efficiently respond to mechanical stress, leading to fibrillation and erosion down to subchondral bone. Recent OA research has sought to identify modalities which retard, or even reverse these pathological events. While many claims of disease modifying drugs in OA (DMOAD) have been made, our research has indicated that calcium pentosan polysulfate (CaPPS) exhibits considerable potential in this regard. CaPPS corrects many of the phenotypic imbalances (described above) in chondrocyte metabolism and promotes the synthesis of large PGs. Furthermore, it inhibits the enzymes responsible for PG and collagen degradation and increases the translation of tissue inhibitor of metalloproteinase-3 (TIMP-3) by synoviocytes and chondrocytes, thereby, reducing proteolytic and angiogenic activity within the joint space.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>12014849</pmid><doi>10.1023/a:1015219716583</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1389-5729
ispartof Biogerontology (Dordrecht), 2002, Vol.3 (1-2), p.85-88
issn 1389-5729
1573-6768
language eng
recordid cdi_proquest_miscellaneous_71691604
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Apoptosis
Biological and medical sciences
Cartilage
Cartilage, Articular - anatomy & histology
Cartilage, Articular - physiology
Diseases of the osteoarticular system
Extracellular Matrix - metabolism
Free radicals
Humans
Juxtaarticular diseases. Extraarticular rhumatism
Medical sciences
Osteoarthritis - genetics
title Osteoarthritis, genetic and molecular mechanisms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A13%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteoarthritis,%20genetic%20and%20molecular%20mechanisms&rft.jtitle=Biogerontology%20(Dordrecht)&rft.au=GHOSH,%20Peter&rft.date=2002&rft.volume=3&rft.issue=1-2&rft.spage=85&rft.epage=88&rft.pages=85-88&rft.issn=1389-5729&rft.eissn=1573-6768&rft_id=info:doi/10.1023/a:1015219716583&rft_dat=%3Cproquest_pubme%3E2156603781%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=756906388&rft_id=info:pmid/12014849&rfr_iscdi=true